Mutations in the voltage-gated sodium channels SCN1A and SCN2A are responsible for several types of human epilepsy. Variable expressivity among family members is a common feature of these inherited epilepsies, suggesting that genetic modifiers may influence the clinical manifestation of epilepsy. The transgenic mouse model Scn2a Q54 has an epilepsy phenotype as a result of a mutation in Scn2a that slows channel inactivation. The mice display progressive epilepsy that begins with short-duration partial seizures that appear to originate in the hippocampus. The partial seizures become more frequent and of longer duration with age and often induce secondary generalized seizures. Clinical severity of the Scn2a Q54 phenotype is influenced by genetic background. Congenic C57BL/6J.Q54 mice exhibit decreased incidence of spontaneous seizures, delayed seizure onset, and longer survival in comparison with [C57BL/6J · SJL/J]F 1 .Q54 mice. This observation indicates that strain SJL/J carries dominant modifier alleles at one or more loci that determine the severity of the epilepsy phenotype. Genome-wide interval mapping in an N 2 backcross revealed two modifier loci on Chromosomes 11 and 19 that influence the clinical severity of of this sodium channel-induced epilepsy. Modifier genes affecting clinical severity in the Scn2a Q54 mouse model may contribute to the variable expressivity seen in epilepsy patients with sodium channel mutations.
Introduction
Mutations in voltage-gated sodium channels associated with human epilepsy were first identified in the disorder Generalized Epilepsy with Febrile Seizures Plus (GEFS+) (Wallace et al. 1998 ; Escayg et al. 2000) . GEFS+ is a heterogeneous syndrome in which affected family members have febrile seizures in childhood which may progress to other seizure types later in life. More than 150 mutations in the sodium channels SCN1A and SCN2A have been identified in human patients (reviewed in Meisler and Kearney 2005) . The variable expressivity among family members with the same primary mutation suggests that the clinical severity depends on secondary factors which may include genetic modifiers.
We have developed a mouse model with a missense mutation of Scn2a, designated Scn2a
Q54
, with an epilepsy phenotype that resembles human patients (Kearney et al. 2001 ). Scn2a Q54 mice express a transgene in which expression of the Scn2a GAL879À881QQQ cDNA (abbreviated Scn2a Q54 ) is driven by the neuronspecific enolase (NSE) promoter. The mutation GAL879-881QQQ in the cytoplasmic S4-S5 linker of domain 2 results in delayed channel inactivation and increased persistent current when measured in Xenopus oocytes and in hippocampal neurons from Scn2a Q54 transgenic mice (Smith and Goldin 1997; Kearney et al. 2001 ). The level of persistent current in Scn2a Q54 neurons ($2% of total peak current) is comparable to that produced by mutations such as SCN1A R1648H in families with GEFS+ (Lossin et al. 2002) . Scn2a Q54 transgenic mice exhibit progressive epilepsy that begins at 6-8 weeks of age with recurrent, spontaneous partial seizures that appear to originate in the hippocampus (Kearney et al. 2001 ). The electrographic seizures are accompanied by episodes of behavioral arrest, tonic deviation of the head and body, and forelimb clonus (Kearney et al. 2001 ).
Scn2a
Q54 transgenic mice exhibit hippocampal pathology that resembles human mesial temporal lobe epilepsy with neuron loss in areas CA1 and CA3 and in the hilus of the dentate gyrus (Kearney et al. 2001 ). The GEFS+ spectrum includes temporal lobe epilepsy (Abou-Khalil et al. 2001 ). Line C57BL/6J.Q54 was established by backcrossing a (C57BL/6J · SJL/J)F 2 founder to strain C57BL/6J. Offspring from the first and second backcross generations (N 1 and N 2 ) were used to characterize the phenotype described in Kearney et al. (2001) . Twelve percent to 25% of the genome of these mice is derived from strain SJL/J.
We have established the congenic line C57BL/ 6J.Q54 (abbreviated B6.Q54) by ten generations of backcrossing to strain B6. This line is estimated to contain less than 0.1% of SJL-derived DNA (Silver 1995) . We describe a strain difference in the Scn2a Q54 phenotype between the congenic B6.Q54 line and the (B6 · SJL/J)F 1 background. This suggests that strain SJL/J carries alleles at one or more modifier loci that increase the incidence and severity of seizures caused by the Scn2a Q54 mutation. We report the results of analysis of an N 2 backcross that reveals two modifier loci that influence epilepsy susceptibility due to a sodium channel mutation.
Materials and methods

Mice. Scn2a
Q54 transgenic mice (TgN54Mm) were generated by microinjection of (C57BL/6J · SJL/J)F 2 oocytes as described (Kearney et al. 2001 ). The congenic line C57BL/6J.Q54 (abbreviated B6.Q54) was established by ten successive generations of backcrossing to strain C57BL/6J and is maintained by continued backcrossing of hemizygous transgenic males to C57BL/6J females. Strain SJL/J was crossed to B6.Q54 to generate (B6.Q54 · SJL)F 1 offspring. For mapping, (B6.Q54 · SJL)F 1 mice were backcrossed to strain C57BL/6J. SJL/J (stock No. 00686) and C57BL/ 6J (stock No. 00064) mice were obtained from The Jackson Laboratory (Bar Harbor, ME). The doubleridge (dblr) mouse mutant was identified in a screen for insertional mutants and found to be caused by a transgene insertion on the SJL/J-derived Chromosome 19 of the founder (MacDonald et al. 2004 ). The incipient congenic line B6.dblr with the interval of Chromosome 19 containing the SJL/J-derived dblr mutation has been backcrossed to C57BL/6J for eight generations and is estimated to contain less than 2% of SJL-derived DNA (Silver 1995 Genetic analysis. Association between genotypes and the presence of epilepsy at each locus was first assessed by single-marker analysis using logistic regression, wherein the significance of shifts in allelic proportions was determined by an odds-ratio test. We then used interval mapping, using a maximum-likelihood procedure designed for categorical traits (Galecki et al. 2001 ). We refer to this method as categorical trait interval mapping (CTIM). CTIM takes as its underlying model an example of a latent class model in which a categorical (here, dichotomous) phenotype is treated as a function of both the unknown (unobservable) genotype at a putative marker and the known (observable) geno-type at flanking markers. Under this model each probability defining the joint distribution of phenotype data and unobservable genotypes (complete data) is decomposed into the product of two underlying probabilities: Prob(phenotype|unobservable genotype) · Prob(unobservable genotype). Component probabilities are then modeled using logistic regression and HaldaneÕs mapping function, respectively. This model may also be considered an elaboration of generalized linear models, with a composite link function applied to odds ratios and binomial distribution ( Significance of single-marker peaks can be evaluated in terms of the expected incidence of false positives (type I errors). In single-marker analysis, the LOD score (and corresponding v 2 ) threshold for an experiment-wise a value of 0.05 (i.e., a 5% chance of obtaining at least one association of marker to trait, purely by chance, anywhere in the genome ) was estimated empirically (Churchill and Doerge 1994) by determining the v 2 statistics for each marker over 1000 permutations of the trait category assigned to each genotype.
Candidate gene screening. Positional candidate genes were identified from the publicly available mouse genome sequence (www.ensembl.org) and selected by tissue expression and gene function. Primers were designed using Oligo Primer Analysis software (ver. 6.65, Molecular Biology Insights, Cascade, CO). Genes were amplified from B6 and SJL by RT-PCR or by PCR of exon sequence from genomic DNA. PCR products were gel-purified and sequenced on an ABI 3730 Automated Sequencer in The University of Michigan DNA Sequencing Core Facility. Sequences were compared using Sequencher software (GeneCodes, Ann Arbor, MI).
Results
Effect of genetic background. Scn2a Q54 transgenic mice were generated by microinjection of (C57BL/6J · SJL/J)F 2 eggs as previously described (Kearney et al. 2001 ). The initial characterization used mice from the first (N 1 ) and second (N 2 ) C57BL/6J backcross generations with 12%À25% of the genome derived from strain SJL/J (Kearney et al. 2001 ). We have carried out ten successive generations of backcrossing to transfer the Scn2a Q54 transgene onto the C57BL/6J background, establishing the congenic line C57BL/6J.Q54 (abbreviated B6.Q54). This line is estimated to contain less than 0.1% of SJL/J-derived DNA (Silver 1995) . The phenotype of the congenic line was found to be much less severe than in the N 1 and N 2 mice, with low incidence, delayed onset and reduced severity of seizures, and increased longevity.
To determine whether the reduced severity resulted from loss of SJL/J alleles at modifier loci, we crossed the B6.Q54 congenic mice to strain SJL/J. The resulting (SJL · B6)F 1 .Q54 offspring (abbreviated F 1 .Q54) were genotyped at P14 and observed in 30-min sessions at 3, 4.5, and 6 weeks of age. A comparison of the phenotype in F 1 .Q54 and B6.Q54 mice is presented in Fig. 1 . F 1 .Q54 mice exhibited high incidence of seizures (>80%) with early onset (Fig. 1A) . In contrast, B6.Q54 mice exhibited a low incidence of seizures, with less than 20% having seizures at 3 months of age (Fig. 1A) . Affected F 1 animals have a high seizure frequency of 8-16 per 30 min, while seizure frequency is low in the small number of B6.Q54 mice that exhibit seizures (Fig. 1B) . Fewer than 25% of F 1 .Q54 mice survive to 6 months of age compared with greater than 75% of the congenic B6.Q54 mice (Fig. 1C) . The data indicate that strain SJL/J carries alleles at one or more loci that influence susceptibility to epilepsy caused by the Scn2a mutation.
Backcross mapping of modifier loci. To localize loci responsible for the strain difference in seizure susceptibility between B6.Q54 and F 1 .Q54 mice, we carried out a backcross of F 1 .Q54 mice to strain C57BL/6J. Backcross progeny carrying the Scn2a )6 ) indicates that there is more than one locus responsible for the phenotype difference between strains. This seizure incidence in the N 2 backcross population is intermediate between the parental strains (Fig. 3) .
A 20-cM-resolution genome scan, including 90 microsatellite markers with an average spacing of 14.9 cM, was carried out on 79 backcross DNAs, including 38 susceptible and 41 resistant. Genotyping of additional N 2 animals was performed on chromosomes with significant association by single-marker analysis. The Scn2a Q54 transgene insertion site was localized to mouse Chromosome 1 between 58 and 70 cM (94À103 Mb), reducing the ability to detect modifiers on this chromosome.
Modifier loci affecting epilepsy susceptibility resulting from a sodium channel mutation were mapped using CTIM analysis. The genome-wide significance threshold of p = 0.05 corresponding to a LOD score of 2.6 was determined with 1000 permutations of the trait data with respect to observed genotypes. CTIM analysis provided suggestive or significant evidence for two modifier loci on Chromosomes 11 and 19 (Fig. 2) The combined effect of Moe1 and Moe2 accounts for approximately 80% of the difference in seizure incidence between B6.Q54 and F 1 .Q54 mice. Inheritance of three susceptible alleles, including two B6 alleles at Moe1 and an SJL allele at Moe2, results in seizure incidence approaching that of the F 1 .Q54 mice (Fig. 3) . Conversely, inheritance of one susceptible allele and three resistant alleles at these loci (Moe1 BS , Moe2 BB ) results in seizure incidence similar to B6.Q54 mice (Fig. 3) .
Chromosome 19 interval-specific strain. The B6.dblr mouse strain carries an SJL/J-derived segment of Chromosome 19 that spans the Moe2 1-LOD support interval from D19Mit86 to D19Mit88 (Fig. 4A) . The dblr mutation was caused by a transgene insertion with a 60-kb intergenic deletion of mouse Chromosome 19, resulting in decreased expression of the Wnt signaling inhibitor Dkk1 A. Incidence of seizures in F 1 .Q54 and B6.Q54 mice at 1À3 months of age. B. Average number of seizures in F 1 .Q54 and B6.Q54 mice at 3, 4.5, and 6 weeks of age (*p < 1e )9 ). C. Reduced lifespan in F 1 .Q54 mice compared with that of B6.Q54. dblr mutation have defects in forelimb development (Adamska et al. 2003) . Heterozygous dblr/+ mice do not display spontaneous seizures or increased susceptibility to seizures induced by pentylenetetrazol (40 and 50 mg/kg i.p.) (data not shown).
To confirm the mapping of the Moe2 locus on Chromosome 19, we crossed B6.dblr/+ mice with B6.Q54 mice. Offspring were genotyped for Scn2a Q54 , the dblr mutation, and the microsatellite markers D19Mit86, D19Mit135, and D19Mit133. Scn2a Q54 transgene-positive offspring underwent 30-min observations for spontaneous seizures at 3, 4.5, and 6 weeks of age. B6.Q54 mice carrying the SJLderived dblr interval of Chromosome 19 exhibited a higher incidence of spontaneous seizures than B6.Q54 mice (v 2 = 8.3, p < 0.004) (Fig. 4B ). The increased incidence of seizures in (B6.Q54, dblr/+) mice supports the mapping of Moe2 to Chromosome 19.
To test the effect of reduced levels of Dkk1 on seizure susceptibility, we crossed B6.Q54 mice with Dkk1 +/) null heterozygotes (Mukhopadhyay et al. 2001 ). (B6.Q54, Dkk1 +/) ) mice do not exhibit increased seizure incidence compared with the (B6.Q54, Dkkl +/+ ) littermates (data not shown), indicating that reduced expression of Dkk1 does not account for the increased seizure susceptibility of (B6.Q54, dblr/+) mice.
Positional candidate genes. The Moe1 and Moe2 regions were examined for strong candidate genes in the publicly available mouse genome sequence (www.ensembl.org). In the Moe1 region of Chromosome 11, candidate genes included two inwardly rectifying potassium channels (Kcnj2, Kcnj16) and seizure-related gene 6 (Sez6). In the Moe2 region on Chromosome 19, candidate genes included a high-affinity glutamate transporter (Slc1a1), a serotonin receptor (Htr7), the very-lowdensity lipoprotein receptor (Vldlr), and two tumor suppressor genes that have been associated with seizures in mice (Pten) (Backman et al. 2001 ) and human patients (Lgi1) (Kalachikov et al. 2002) . We screened for coding sequence polymorphisms in these candidate genes by RT-PCR or by PCR of ex- onic sequence from B6 and SJL genomic DNA. No coding sequence polymorphisms were observed. Regulation of expression was not evaluated.
Discussion
We report an effect of strain background on the severity of epilepsy caused by a sodium channel mutation. Genetic analysis of an N 2 backcross identified two modifier loci that influence the severity of epilepsy in Scn2a Q54 mice. This is in agreement with previous studies that have shown seizure susceptibility and severity to be under genetic influence (Frankel et The phenotyping of mice in our mapping backcross divided animals into two categories based on the presence or absence of seizures. The categorical nature of our data precluded the use of conventional interval mapping procedures which assume that trait data are continuous and normally distributed. Methods for analysis of such data include nonparametric interval mapping, which makes no assumptions about the distribution of the trait data (Kruglyak and Lander 1995) , and categorical traits interval mapping (CTIM), which is a Bayesian maximum-likelihood procedure for analysis of categorical traits (Galecki et al. 2001 ). Ayyadevara et al. (2003) performed a direct comparison of nonparametric interval mapping and CTIM in a study of lifespan of C. elegans. They found that both methods yielded consistent results but observed sharper peaks with CTIM mapping resulting in smaller 95% confidence intervals and assert that CTIM represents a more appropriate statistical model for categorical trait data (Ayyadevara et al. 2003) .
Loci responsible for strain differences in susceptibility to seizures induced by handling, kainate, pentylenetetrazol, and electroconvulsive shock have been mapped to specific mouse chromosomes (Frankel et al. 1995; Ferraro et al. 1997 Ferraro et al. , 1999 ; Ferraro et al. 2001 Ferraro et al. , 2002 Ferraro et al. , 2004 . QTLs influencing seizure-induced cell death have also been mapped in strains C57BL/ 6J (resistant) and FVB/N (susceptible) (Schauwecker et al. 2004) . Previous studies have shown that strain C57BL/6J is resistant to seizures induced by a variety of methods, including chemoconvulsants, electroconvulsive shock, audiogenic, and handling (Seyfried et al. 1980; Ferraro et al. 1997 Ferraro et al. , 1999 Ferraro et al. , 2001 Frankel et al. 2001; Ferraro et al. 2002; Kitami et al. 2004 ). Little has been reported about the seizure susceptibility of strain SJL/J. However, the limited reports on SJL and the demonstrated susceptibility of the closely related strain FVB/NJ suggest that SJL is likely to be on the susceptible end of the spectrum (Frankel et al. 2001; Golden et al. 2001; Chen et al. 2005) .
A major-effect seizure susceptibility QTL (designated Szs1) has been mapped to distal Chromosome 1 by studies of strain differences in susceptibility to seizures induced by kainate, pentylenetetrazol, and maximal electroshock (Ferraro et al. 1997 (Ferraro et al. , 1999 (Ferraro et al. , 2002 (Ferraro et al. , 2004 . Ferraro et al (2004) suggested that the potassium channel Kcnj10 variant T262S is a likely candidate for Szs1. In support of this, a significant association was demonstrated between seizure resistance and the variant R271C in the human ortholog KCNJ10 (Buono et al. 2004 ). In our N 2 backcross, Szs1 segregated independent of seizure phenotype, indicating that it does not contribute to the observed difference in epilepsy severity between strains B6 and SJL.
Two previous studies identified seizure susceptibility QTLs on Chromosome 11 in regions overlapping the Moe1 locus. QTL mapping in the epilepsy-susceptible EL mouse strain identified the locus El6 on Chromosome 11 at which homozygosity for the allele from the resistant DDY/Jcl strain confers increased susceptibility to seizures (peak 68 cM) (Frankel et al. 1995) . The QTL Szs3 was mapped to the same region in a study of kainate-induced seizure susceptibility in strains DBA/2J and C57BL/ 6J (peak 66 cM). Homozygosity of the Szs3 allele from the resistant B6 strain at this locus confers increased susceptibility to seizures (Ferraro et al. 1997 ). In our study, Moe1 maps to the same region, and homozygosity for the allele from the resistant B6 strain also confers increased epilepsy susceptibility, suggesting that Szs3 and Moe1 may reflect the effect of the same B6 allele.
The epilepsy susceptibility locus Moe2 on Chromosome 19 was confirmed by using a congenic mouse strain with this interval derived from strain SJL/J. We used the B6.dblr mouse strain with an SJLderived interval on Chromosome 19. This provided a useful resource for confirmation of the Moe2 locus, circumventing the need to generate an interval-specific congenic strain. Compared with littermates without the SJL-derived Chromosome 19 interval, (B6.Q54, dblr/+) mice had increased seizure incidence. The mutation in heterozygous dblr/+ mice results in a 20% reduction in expression of the Wnt inhibitor Dkk1 (MacDonald et al. 2004). As a control for the effect of reduced Dkk1 expression, a heterozygous null allele of Dkk1 with a 50% reduction in Dkk1 expression did not influence the epilepsy phenotype of Scn2a Q54 mice. This supports the hypothesis that the increased epilepsy susceptibility is a result of the SJL-derived interval of Chromosome 19. This region of Chromosome 19 has not been associated with seizure susceptibility or severity in previous QTL studies and represents a novel epilepsy susceptibility locus.
The 1-LOD support interval of the Moe1 locus on Chromosome 11 contains more than 500 known and predicted genes and the Moe2 locus contains more than 150 known and predicted genes. Likely candidate genes include ion channels, receptors, neurotransmitters and neuromodulators, transcription factors, and genes involved in neural development and injury response. Polymorphisms that result in changes in protein sequence or variants in regulatory elements are likely to underlie the genetic difference in seizure susceptibility between strains. Large-scale copy number polymorphisms are another type of variation whose role in genetic diversity is just beginning to be appreciated (Sebat et al. 2004 ). We screened the coding sequence of a small number of candidate genes but did not identify any coding polymorphisms.
More than 150 mutations in voltage-gated sodium channels have been identified in patients with epilepsy. Variable expressivity is a common feature of inherited epilepsy caused by sodium channel mutations because family members with the same mutation exhibit differences in the clinical severity of epilepsy. For example, in one GEFS+ family carrying the K1270T mutation in SCN1A, nine family members had isolated febrile seizures and five family members have TLE (Abou-Khalil et al. 2001). In another family with the T875M mutation in SCN1A, half of the family members had isolated febrile seizures while the other half had more severe seizure types including generalized tonic-clonic, absence, atonic, and hemicorporeal seizures (Moulard et al. 1999; Escayg et al. 2000) . This variable expressivity suggests that other factors besides the primary sodium channel mutation influence the clinical manifestation of epilepsy in human patients. This could include stochastic events during development, accumulation of somatic mutations (Weiss 2005) , environmental insults such as trauma, and differences in inheritance of genetic susceptibility alleles such as these mapped in the current study. Isolation of susceptibility genes and analysis of the underlying pathophysiology will contribute to understanding the molecular events of epileptogenesis and identify novel therapeutic targets.
